Literature DB >> 14499635

Leukotriene D4-induced adhesion of Caco-2 cells is mediated by prostaglandin E2 and upregulation of alpha2beta1-integrin.

Ramin Massoumi1, Christian Kamp Nielsen, Denijal Azemovic, Anita Sjölander.   

Abstract

Cell-cell and extracellular matrix adhesions play important roles in the progression of cancer. We investigated the involvement of the inflammatory mediator leukotriene D4 (LTD4) in the regulation of cell-matrix adhesion of colon cancer (Caco-2) cells. We observed that LTD4 acted via its CysLT1 receptor in these cells to induce increased adhesion to collagen I. LTD4 also enhanced the activation and expression of alpha2beta1-integrins on the cell surface, which we found to be responsible for mediating the increased adhesion to collagen I. LTD4 simultaneously augmented expression of the prostaglandin-generating enzyme cyclooxygenase-2 (COX-2) and increased prostaglandin E2 (PGE2) production in Caco-2 cells. The adhesive capacity of the Caco-2 cells was reduced by specific inhibition of COX-2 and was subsequently restored by PGE2, but not by LTD4. A selective PGE2 receptor antagonist abolished the increased adhesion and the augmented alpha2beta1-integrin expression induced by both PGE2 and LTD4. Summarizing, the inflammatory mediator LTD4 regulates the adhesive properties and migration of the Caco-2 cell line by upregulating COX-2 and stimulating PGE2-induced expression of alpha2beta1-integrins. This suggests that inflammatory mediators such as LTD4 can be involved in the dissemination and survival of colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499635     DOI: 10.1016/s0014-4827(03)00285-4

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Rotavirus replication in intestinal cells differentially regulates integrin expression by a phosphatidylinositol 3-kinase-dependent pathway, resulting in increased cell adhesion and virus yield.

Authors:  Peter Halasz; Gavan Holloway; Stephen J Turner; Barbara S Coulson
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

2.  EP3 enhances adhesion and cytotoxicity of NK cells toward hepatic stellate cells in a murine liver fibrosis model.

Authors:  Xixi Tao; Rui Zhang; Ronglu Du; Tingting Yu; Hui Yang; Jiwen Li; Yuhong Wang; Qian Liu; Shengkai Zuo; Xi Wang; Michael Lazarus; Lu Zhou; Bangmao Wang; Ying Yu; Yujun Shen
Journal:  J Exp Med       Date:  2022-04-14       Impact factor: 14.307

3.  Prostaglandins in cancer cell adhesion, migration, and invasion.

Authors:  David G Menter; Raymond N Dubois
Journal:  Int J Cell Biol       Date:  2012-02-29

4.  Regulation of cysteinyl leukotriene receptor 2 expression--a potential anti-tumor mechanism.

Authors:  Cecilia Magnusson; Astrid M Bengtsson; Minghui Liu; Jian Liu; Yvonne Ceder; Roy Ehrnström; Anita Sjölander
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

Review 5.  Focus on cutaneous and uveal melanoma specificities.

Authors:  Charlotte Pandiani; Guillaume E Béranger; Justine Leclerc; Robert Ballotti; Corine Bertolotto
Journal:  Genes Dev       Date:  2017-04-15       Impact factor: 11.361

6.  CD47 regulates collagen I-induced cyclooxygenase-2 expression and intestinal epithelial cell migration.

Authors:  Oliver Jay Broom; Yuan Zhang; Per-Arne Oldenborg; Ramin Massoumi; Anita Sjölander
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

7.  Leukotriene D4-induced Caco-2 cell proliferation is mediated by prostaglandin E2 synthesis.

Authors:  Marisol Cabral; Raquel Martín-Venegas; Juan J Moreno
Journal:  Physiol Rep       Date:  2015-07

8.  Cysteinyl leukotrienes mediate lymphokine killer activity induced by NKG2D and IL-15 in cytotoxic T cells during celiac disease.

Authors:  Fangming Tang; Benjamin Sally; Kathryn Lesko; Valentina Discepolo; Valerie Abadie; Cezary Ciszewski; Carol Semrad; Stefano Guandalini; Sonia S Kupfer; Bana Jabri
Journal:  J Exp Med       Date:  2015-08-24       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.